News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients
Françoise Meunier
Jun 12, 2025, 18:16

Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients

Françoise Meunier, Founder of the European Initiative on Ending Discrimination Against Cancer Survivors, shared a post on LinkedIn:

“A highly relevant new publication in the Journal of the National Cancer Center highlights why Member States must act decisively when transposing the Consumer Credit Directive into national law and when adopting the national legal framework with a 5-year timeline:
‘Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients’
The data shows that for most adolescent and young adult breast cancer survivors; excess mortality becomes minimal within just a few years. This is exactly the kind of evidence that justifies a 5-year timeframe for the Right to Be Forgotten.
This is a pivotal moment for policymakers: transposing the Directive with ambition and evidence in mind is critical to protecting cancer survivors from ongoing financial discrimination.”

Title: Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype

Journal: The National Cancer Center

Authors: Noëlle J.M.C. Vrancken Peeters, Daniël J. van der Meer, Marleen Kok, Marissa C. van Maaren, Marie-Jeanne T.F.D. Vrancken Peeters, Sabine Siesling, Winette T.A. van der Graaf, Olga Husson

Read the full article.

Breast Cancer

More posts featuring Françoise Meunier on OncoDaily.

cancer cancer survivors Consumer Credit Directive Daniël J. van der Meer Françoise Meunier Journal of the National Cancer Center Marie-Jeanne T.F.D. Vrancken Peeters Marissa C. van Maaren Marleen Kok Noëlle J.M.C. Vrancken Peeters Olga Husson OncoDaily Oncology Sabine Siesling Winette T.A. van der Graaf
Special Coverage
Insight
Jun 12, 2025, 18:16
Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients
Blog
Jun 12, 2025, 18:03
Ashley Love Sumrall: Reflecting on Experiences After ASCO and AMA Meetings
Blog
Jun 12, 2025, 17:47
Mark Lewis: It’s Only "Practice-Changing" If Patients See Benefit and Are Willing to Act Post-ASCO25
Blog
Jun 12, 2025, 17:42
The Max Foundation Highlighted Satish Tulsidás and Breast Cancer Care at Central Hospital of Maputo in Mozambique
Science
Jun 12, 2025, 17:31
Yüksel Ürün: Alarming Rise in Cancers Under 50
Insight
Jun 12, 2025, 17:18
Shankar Siva: Will the VALOR Trial Show No Difference Between Surgery and SABR in Stage I Lung Cancer?
Blog
Jun 12, 2025, 17:15
Medical Talk Mastering 2025: The Essential Course For Medical Professionals - European School of Oncology
Blog
Jun 12, 2025, 17:03
Small Steps, Big Living - A Lifestyle Medicine Approach to Cancer Survivorship: Sami Mansfield
Blog
Jun 12, 2025, 16:59
Congratulations to Our Newest MASCC-Designated Center of Excellence in Supportive Care in Cancer - MASCC
Blog
Jun 12, 2025, 15:54
Submit Your Case Study for the CCI4EU 9th Online Course - Organisation of European Cancer Institutes
Insight
Jun 12, 2025, 15:53
Yan Leyfman Highlighted Study Published in Science on Vascularized Cardiac and Hepatic Organoids
Blog
Jun 12, 2025, 15:42
Sameer Raastogi Shared Phase 2 Trial Results For Low-dose Regorafenib in Relapsed Synovial Sarcoma